SEC Comment Letter for TENAX THERAPEUTICS, INC. (TENX) (CIK 0000034956) (TENX) — May 22, 2018
TENAX THERAPEUTICS, INC. (TENX) (CIK 0000034956)
Date: May 22, 2018 · CIK: 0000034956 · Accession: 0000000000-18-015768
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-224951
Letter
Mail Stop 3561 May 21 , 2018 Via E -Mail Michael B. Jebsen President Tenax Therapeutics, Inc. One Copley Parkway, Suite 490 Morrisville, NC 27560
Re: Tenax Therapeutics, Inc. Registration Statement on Form S-3 Filed May 15 , 2018 File No. 333-224951
Dear Mr. Jebsen :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jonathan Burr at (202) 551 -5833 with any questions.
Sincerely,
/s/ James Lopez (for)
Show Raw Text
Mail Stop 3561 May 21 , 2018 Via E -Mail Michael B. Jebsen President Tenax Therapeutics, Inc. One Copley Parkway, Suite 490 Morrisville, NC 27560 Re: Tenax Therapeutics, Inc. Registration Statement on Form S-3 Filed May 15 , 2018 File No. 333-224951 Dear Mr. Jebsen : This is to advise you that we have not reviewed and will not review your registration statement . Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jonathan Burr at (202) 551 -5833 with any questions. Sincerely, /s/ James Lopez (for) John Reynolds Assistant Director Office of Beverages, Apparel, and Mining cc: Margaret Rosenfeld Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan, L.L.P.